ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO173

Systemic Amyloid Presenting with Rapidly Worsening Hyperparathyroidism in Patients with ESKD

Session Information

  • CKD-MBD: Clinical
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Ong, Yi-Ting, Singapore General Hospital, Singapore, Singapore
  • Andres, Julia G., Singapore General Hospital, Singapore, Singapore
  • Wong, Jiunn, Singapore General Hospital, Singapore, Singapore
Introduction

Hypercalcemia in ESKD patients is commonly associated with tertiary hyperparathyroidism and can be challenging to manage. We report a case of unusually severe PTH-mediated symptomatic hypercalcemia in a hemodialysis patient though to be secondary to rapidly deteriorating hyperparathyroidism. She failed medical therapy and underwent parathyroidectomy. Subsequent histology shows presence of amyloid deposit in the parathyroid specimen. Our case is unusual for rapidly worsening hypercalcemia and hyperparathyroidism and histology finding of amyloid deposit in the parathyroid specimen. We postulated the worsening of hyperparathyroidism and hypercalcemia was related to the amyloid infiltrate in the parathyroid gland

Case Description

A 67-year-old woman with background history of ESKD on hemodialysis who has stable hyperparathyroidism from CKD-MBD on medical therapy. She presented with two-week history of gradual functional decline and symptomatic hypercalcemia. Corrected serum calcium was markedly elevated at 3.62mmol/L, with raised iPTH at 117pmol/L. This is significantly higher than her results just 1 month prior to presentation. Ultrasound showed a well-defined 29 x 22 x 12mm hyperechoic nodule posterior to the right thyroid lower pole, consistent with a parathyroid adenoma which was congruent with a region of increased sestamibi tracer uptake with delayed tracer washout on parathyroid scintigraphy. Despite treatment with repeated sessions of hemodialysis, maximal doses of cinacalcet, calcitonin and anti-resorptives, her calcium levels remained high. She underwent parathyroidectomy with expected response in iPTH levels and improvement of hypercalcemia. Histology subsequently reviewed congo red deposit within intertrabecullar, perifollicular and paracortical stroma of parathyroid, thyroid and lymph node tissue.

Discussion

Unexplained rapidly worsening hypercalcemia in secondary hyperparathhyroidsm should prompt clinician to investigate for alternative cause of hypercalcemia and systemic amyloid may present with severe hypercalcemia and hyperparathyroidism